Reported Tuberculosis in the United States, 2022

Return to Main Menu

Table 33. Tuberculosis Genotyping Surveillance Coverage:1 Reporting Areas, 2022

Tuberculosis cases by genotyping surveillance coverage and reporting area.
State Total cases Culture-positive cases Genotyped cases Genotype surveillance coverage2 (%)
United States3 8,331 6,610 6,343 (96.0)
Alabama 65 59 54 (91.5)
Alaska 95 68 68 (100.0)
Arizona 154 132 132 (100.0)
Arkansas 68 49 43 (87.8)
California 1,848 1,532 1,473 (96.1)
Colorado 57 52 52 (100.0)
Connecticut 67 51 51 (100.0)
Delaware 13 10 10 (100.0)
District of Columbia 15 12 12 (100.0)
Florida 535 419 414 (98.8)
Georgia 262 192 190 (99.0)
Hawaii 101 76 76 (100.0)
Idaho 11 8 8 (100.0)
Illinois 298 223 209 (93.7)
Indiana 99 73 73 (100.0)
Iowa 60 44 43 (97.7)
Kansas 52 44 39 (88.6)
Kentucky 70 51 50 (98.0)
Louisiana 95 86 56 (65.1)
Maine 17 13 13 (100.0)
Maryland 157 113 112 (99.1)
Massachusetts 153 132 122 (92.4)
Michigan 120 65 65 (100.0)
Minnesota 132 103 103 (100.0)
Mississippi 54 45 40 (88.9)
Missouri 69 59 55 (93.2)
Montana 6 5 0 (0.0)
Nebraska 29 22 20 (90.9)
Nevada 62 54 54 (100.0)
New Hampshire 11 9 6 (66.7)
New Jersey 289 230 227 (98.7)
New Mexico 30 23 23 (100.0)
New York State4 178 137 121 (88.3)
New York City 536 460 448 (97.4)
North Carolina 163 128 127 (99.2)
North Dakota 10 5 5 (100.0)
Ohio 146 102 101 (99.0)
Oklahoma 80 52 45 (86.5)
Oregon 73 58 57 (98.3)
Pennsylvania 173 145 143 (98.6)
Rhode Island 17 10 9 (90.0)
South Carolina 101 74 73 (98.6)
South Dakota 10 7 7 (100.0)
Tennessee 106 71 67 (94.4)
Texas 1,098 874 827 (94.6)
Utah 33 24 24 (100.0)
Vermont 3 2 2 (100.0)
Virginia 195 150 149 (99.3)
Washington 251 201 195 (97.0)
West Virginia 11 9 7 (77.8)
Wisconsin 52 46 42 (91.3)
Wyoming 1 1 1 (100.0)
American Samoa – – – – – – – –
Federated States of Micronesia 51 27 27 (100.0)
Guam 59 52 52 (100.0)
Republic of the Marshall Islands 106 25 24 (96.0)
Northern Mariana Islands 23 14 6 (42.9)
Puerto Rico 22 20 19 (95.0)
Republic of Palau 7 5 5 (100.0)
U.S. Virgin Islands – – – – – – – –

1Genotype surveillance coverage is defined as the percentage of all culture-positive cases for which there was a genotyped isolate.
2National TB Performance Indicator goal for national TB genotyping surveillance coverage is 100.0%.
3American Samoa, Federated States of Micronesia, Guam, Republic of the Marshall Islands, Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin Islands are not included in the U.S. totals and percentages.
4Excludes New York City.

Note:
Data for all years are updated through July 8, 2023.

Double dashes (– –) indicate that data are not available.

See Technical Notes